密苏里大学计划10亿美元的核反应堆来增加癌症治疗同位素。 University of Missouri plans $1 billion nuclear reactor to boost cancer treatment isotopes.

密苏里大学正与韩国公司合作,建造一个新的10亿美元的NextGen核研究反应堆。 The University of Missouri is building a new $1 billion NextGen nuclear research reactor in partnership with South Korean companies. 这一反应堆预定在大约10年内完成,将把目前的反应堆面积增加一倍,达到20兆瓦,大大提高其生产用于癌症治疗的放射性同位素的能力。 This reactor, set to be completed in about 10 years, will double the current reactor's size to 20 megawatts, significantly increasing its capacity to produce radioisotopes used in cancer treatments. 该大学已获得2亿美元,剩余资金将通过捐助者和联邦支助筹集。 The university has secured $200 million, with the remaining funds to be raised through donors and federal support. 该项目旨在加强用于治疗癌症的关键医用同位素的生产,特别是177。 The project aims to enhance the production of critical medical isotopes, particularly Lutetium-177, for cancer treatments.